ITRM920270A1 - Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. - Google Patents
Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.Info
- Publication number
- ITRM920270A1 ITRM920270A1 IT000270A ITRM920270A ITRM920270A1 IT RM920270 A1 ITRM920270 A1 IT RM920270A1 IT 000270 A IT000270 A IT 000270A IT RM920270 A ITRM920270 A IT RM920270A IT RM920270 A1 ITRM920270 A1 IT RM920270A1
- Authority
- IT
- Italy
- Prior art keywords
- prevention
- treatment
- pharmaceutical composition
- oral mucosa
- inflammations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920270A IT1254321B (it) | 1992-04-10 | 1992-04-10 | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. |
EP93830139A EP0565495A1 (en) | 1992-04-10 | 1993-04-02 | Pharmaceutical composition containing glycyrrhetinic acid and phenanthridine alkaloids |
CA002093401A CA2093401A1 (en) | 1992-04-10 | 1993-04-05 | Pharmaceutical compositions for the treatment and prevention of cutaneous and oral mucous membrane inflammation |
US08/043,493 US5425948A (en) | 1992-04-10 | 1993-04-06 | Pharmaceutical compositions for the treatment and prevention of cutaneous and oral mucous membrane inflammations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920270A IT1254321B (it) | 1992-04-10 | 1992-04-10 | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM920270A0 ITRM920270A0 (it) | 1992-04-10 |
ITRM920270A1 true ITRM920270A1 (it) | 1993-10-10 |
IT1254321B IT1254321B (it) | 1995-09-14 |
Family
ID=11400944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM920270A IT1254321B (it) | 1992-04-10 | 1992-04-10 | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. |
Country Status (4)
Country | Link |
---|---|
US (1) | US5425948A (it) |
EP (1) | EP0565495A1 (it) |
CA (1) | CA2093401A1 (it) |
IT (1) | IT1254321B (it) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US6902738B2 (en) * | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
AU4596796A (en) * | 1995-02-07 | 1996-08-27 | Narayan Krishnarao Athanikar | Concomitant treatment with bismuth and antibacterials |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
GT199700054A (es) * | 1996-05-03 | 1998-10-22 | Pesticidas que contienen alcaloides de benzofenantridina | |
DE19654508C1 (de) * | 1996-12-18 | 1998-08-13 | Lancaster Group Gmbh | Kosmetisches Reinigungs- und Pflegepräparat |
KR100230710B1 (ko) * | 1997-06-26 | 1999-11-15 | 전기영 | 잇몸질환의 예방 및 치료용 조성물 |
US5908640A (en) * | 1997-07-25 | 1999-06-01 | Embro; William J. | Veterinary compositions for treating epidermal irritations |
KR100356697B1 (ko) * | 1998-03-07 | 2002-12-18 | 주식회사 태평양 | 여드름에효과가있는피부용조성물 |
US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
US7151082B2 (en) * | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
US7304034B2 (en) * | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
AUPR726701A0 (en) * | 2001-08-24 | 2001-09-20 | HWF Enterprises Pty Ltd | Compound for treatment of lesions and tumours |
ITMI20020756A1 (it) * | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | Composizioni farmaceutiche topiche per il trattamento delle dermatiti |
US7696169B2 (en) * | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
CA2538763C (en) * | 2003-09-11 | 2015-05-05 | Critical Therapeutics, Inc. | Monoclonal antibodies against hmgb1 |
EP1909834A2 (en) * | 2005-07-18 | 2008-04-16 | Critical Therapeutics, Inc. | Use of hmgb1 antagonists for the treatment of inflammatory skin conditions |
US20080311122A1 (en) * | 2005-11-28 | 2008-12-18 | Medimmune, Llc | Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof |
WO2009043341A2 (de) | 2007-10-02 | 2009-04-09 | Kuhs Gmbh | Topisch zu applizierende kosmetische oder pharmazeutische zusammensetzung |
ITMI20080038A1 (it) * | 2008-01-11 | 2009-07-12 | Indena Spa | Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva |
ITMI20080395A1 (it) * | 2008-03-10 | 2009-09-11 | Indena Spa | Formulazioni per il trattamento delle verruche e delle placche psoriatiche |
US9676696B2 (en) * | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2122893B (en) * | 1982-06-30 | 1985-06-26 | Biorex Laboratories Ltd | Glycyrrhetinic acid compositions |
CA1335076C (en) * | 1987-04-01 | 1995-04-04 | Hanna R. Kowarski | Pharmaceutical composition and method for intranasal administration |
US5175000A (en) * | 1987-06-30 | 1992-12-29 | Vipont Pharmaceutical, Inc. | Free amine benzophenanthridine alkaloid compositions |
NZ232572A (en) * | 1989-03-13 | 1991-11-26 | Vipont Pharma | Oral rinse composition containing a benzophenanthridine alkaloid extract from sanguinaria canadesis |
EP0480996A1 (en) * | 1989-07-07 | 1992-04-22 | Atrix Laboratories, Inc. | Benzophenanthridine alkaloids for topical acne treatment |
JP2998287B2 (ja) * | 1991-03-13 | 2000-01-11 | 千寿製薬株式会社 | グリチルレチン酸誘導体 |
-
1992
- 1992-04-10 IT ITRM920270A patent/IT1254321B/it active
-
1993
- 1993-04-02 EP EP93830139A patent/EP0565495A1/en not_active Withdrawn
- 1993-04-05 CA CA002093401A patent/CA2093401A1/en not_active Abandoned
- 1993-04-06 US US08/043,493 patent/US5425948A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ITRM920270A0 (it) | 1992-04-10 |
IT1254321B (it) | 1995-09-14 |
EP0565495A1 (en) | 1993-10-13 |
CA2093401A1 (en) | 1993-10-11 |
US5425948A (en) | 1995-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITRM920270A1 (it) | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. | |
ATE219377T1 (de) | Neue galenische orale pharmazeutische formulierung | |
DE69326539D1 (de) | Zytotoxische arzneimittel therapie | |
IT8720771A0 (it) | Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare. | |
ITMI921930A1 (it) | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda | |
IT9019112A1 (it) | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina | |
NO20001717D0 (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
ITMI910456A0 (it) | Composizione farmaceutica per il trattamento della cataratta | |
IT1291340B1 (it) | Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale | |
IT8219482A0 (it) | Composizione farmaceutica per la cura di affezioni della cavita'orale. | |
IT8947616A0 (it) | Preparato per il trattamento e la cura delle emorroidi | |
ITRM960827A0 (it) | Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi | |
NO951933D0 (no) | Farmasöytiske formuleringer av ibuprofen | |
IT9021021A0 (it) | Composizioni farmaceutiche per la somministrazione orale di irudina | |
ITMI911439A0 (it) | Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche | |
FR2558062B1 (fr) | Preparation medicamenteuse administrable par voie orale pour le traitement du rhume et/ou de la grippe | |
ITPD920141A1 (it) | Formulazioni farmaceutiche per la somministraziane orale di calcitonina | |
DE69132165D1 (de) | Aconitinverbindung und analgetisches/entzündungshemmendes mittel | |
ITMI920041A0 (it) | Composizioni farmaceutiche somministrabili per via orale idrosolubili ed effervescenti e di gusto gradevole per il trattamento dell'ulcera | |
IT8519776A0 (it) | Preparato per la cura esterna delle emorroidi. | |
ITMI911930A1 (it) | Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico. | |
ITGE940025A0 (it) | Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi. | |
ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia | |
ITMI932494A1 (it) | Composizioni farmaceutiche per uso orale per il trattamento delle manifestazioni ulcerose gastro-duodenali ed esofagee | |
ITBO910490A0 (it) | -composizione farmaceutica per il trattamento delle adiposita' localizzata e della cellulite. |